Clinical Trial Update: Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial completed and results posted evaluating dalteparin for primary venous thromboembolism prophylaxis in pancreatic cancer patients. Sponsor listed: M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Venous Thromboembolism

Drugs mentioned

• FRAGMIN (DALTEPARIN SODIUM)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer, Venous Thromboembolism | Phase 4 | Status: COMPLETED | Results posted: 2016-12-12